Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 34: 920-924, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, S. A.
Right arrow Articles by Patsch, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, S. A.
Right arrow Articles by Patsch, W.

Clinical Chemistry, Vol 34, 920-924, Copyright © 1988 by American Association for Clinical Chemistry

Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma

SA Brown, CE Rhodes, K Dunn, AM Gotto Jr and W Patsch
Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

We studied the effects of different procedures of blood collection and processing on quantification of apolipoprotein A-I (apoA-I) by radioimmunoassay. ApoA-II and apolipoproteins of low- and very-low- density lipoproteins did not cross react in the assay. Analytical recovery of apoA-I at different doses was complete. ApoA-I concentration in pooled human plasma was stable for as long as a year stored at -70 degrees C. Inter- and intra-assay CVs averaged 7% and 5%, respectively. We collected blood from 20 subjects into tubes containing EDTA alone or EDTA with antiproteolytic agents, then separated the plasma either immediately or after 3 h at 4 degrees C. We tested various formulations of antibacterial, antiproteolytic, and anti- oxidant agents added to plasma, measuring apoA-I concentrations either within 24 h of blood collection or after storage of plasma for 6 weeks at -70 degrees C. No significant difference in the concentrations of apoA-I was found in these specimens, regardless of the conditions studied. We conclude that addition of protective agents other than EDTA is not necessary during blood collection or specimen processing for reliable quantification of apoA-I in fresh or frozen human plasma.


The following articles in journals at HighWire Press have cited this article:


Home page
BloodHome page
A. M. Chamberlain, A. R. Folsom, S. R. Heckbert, W. D. Rosamond, and M. Cushman
High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE)
Blood, October 1, 2008; 112(7): 2675 - 2680.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Shahar, L. E. Chambless, W. D. Rosamond, L. L. Boland, C. M. Ballantyne, P. G. McGovern, and A. R. Sharrett
Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
Stroke, March 1, 2003; 34(3): 623 - 631.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. P. Surguchov, G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle
Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia
Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 941 - 947.
[Abstract] [Full Text]


Home page
NEJMHome page
A. A. Nabulsi, A. R. Folsom, A. White, W. Patsch, G. Heiss, K. K. Wu, M. Szklo, and The Atherosclerosis Risk in Communities Study Inve
Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
N. Engl. J. Med., April 15, 1993; 328(15): 1069 - 1075.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.